Skip to main content
. Author manuscript; available in PMC: 2014 Nov 21.
Published in final edited form as: Pflugers Arch. 2013 May 8;465(10):1487–1495. doi: 10.1007/s00424-013-1262-8

Fig. 8.

Fig. 8

Effects of Ac-SDKP on IL-1β-activated NFκB in cardiac fibroblasts. Cardiac fibroblasts were synchronized and treated with vehicle, Ac-SDKP, IL-1β, or Ac-SDKP+ IL-1β for 2.5 h. NFκB activity was assessed by electrophoretic mobility gel shift assay. a Representative gel shift; b quantitative data for NFκB activity; n=10 for each treatment